- Home
- BORR vs MGTX Comparison
BORR vs MGTX Comparison
Compare BORR & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BORR | MGTX |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 909.1M | 744.9M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BORR | MGTX |
|---|---|---|
| Price | $4.31 | $8.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $3.75 | ★ $23.83 |
| AVG Volume (30 Days) | ★ 5.2M | 633.7K |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | ★ 0.46% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $1,024,500,000.00 | $27,417,000.00 |
| Revenue This Year | $1.03 | N/A |
| Revenue Next Year | N/A | $619.95 |
| P/E Ratio | $15.57 | ★ N/A |
| Revenue Growth | 5.83 | ★ 96.83 |
| 52 Week Low | $1.55 | $4.55 |
| 52 Week High | $4.48 | $9.73 |
Technical Indicators
Market Signals| Indicator | BORR | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 77.46 | 52.85 |
| Support Level | $3.25 | $7.60 |
| Resistance Level | $3.34 | $9.13 |
| Average True Range (ATR) | 0.22 | 0.48 |
| MACD | 0.10 | 0.08 |
| Stochastic Oscillator | 88.99 | 59.02 |
Price Performance
Historical ComparisonAbout BORR Borr Drilling Limited
Borr Drilling Ltd is a drilling contractor that owns and operates jack-up rigs of modern and high-specification designs providing drilling services to the oil and gas exploration and production industry. The company operates a fleet of around 16 jack-up drilling rigs. Geographically the activities are carried out through Norway.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.